HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Timothy D Phillips Selected Research

Aflatoxin Poisoning

2/2020A high capacity bentonite clay for the sorption of aflatoxins.
2/2019NovaSil clay for the protection of humans and animals from aflatoxins and other contaminants.
1/2017Development of High Capacity Enterosorbents for Aflatoxin B1 and Other Hazardous Chemicals.
1/2017Evaluation of the efficacy, acceptability and palatability of calcium montmorillonite clay used to reduce aflatoxin B1 dietary exposure in a crossover study in Kenya.
3/2009PAH exposure in a Ghanaian population at high risk for aflatoxicosis.
1/2002Characterization of clay-based enterosorbents for the prevention of aflatoxicosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Timothy D Phillips Research Topics

Disease

6Aflatoxin Poisoning
02/2020 - 01/2002
4Growth Disorders
01/2021 - 09/2013
4Liver Neoplasms (Liver Cancer)
03/2014 - 11/2004
3Starvation
06/2012 - 10/2006
2Neoplasms (Cancer)
01/2021 - 07/2010
2Body Weight (Weight, Body)
07/2014 - 01/2013
2Carcinoma (Carcinomatosis)
07/2014 - 07/2010
2Infections
01/2011 - 11/2010
2HIV Infections (HIV Infection)
07/2010 - 11/2004
1Hepatocellular Carcinoma (Hepatoma)
04/2018
1Liver Diseases (Liver Disease)
04/2018
1Wounds and Injuries (Trauma)
01/2017
1Carcinogenesis
09/2016
1Inflammation (Inflammations)
02/2015
1Colitis
02/2015
1Weight Loss (Weight Reduction)
02/2015
1Chronic Disease (Chronic Diseases)
03/2014
1Weight Gain
09/2013
1Opportunistic Infections (Opportunistic Infection)
01/2011
1Tuberculosis (Tuberculoses)
01/2011
1Persistent Infection
01/2011
1Communicable Diseases (Infectious Diseases)
01/2011
1Vitamin A Deficiency
12/2010
1Hepatitis
11/2010
1Esophageal Neoplasms (Esophageal Cancer)
07/2010

Drug/Important Bio-Agent (IBA)

14AflatoxinsIBA
01/2021 - 11/2004
6ClayIBA
02/2020 - 01/2002
5Aflatoxin B1 (Aflatoxin B)IBA
01/2017 - 01/2011
4FumonisinsIBA
01/2021 - 07/2010
3MetalsIBA
06/2012 - 10/2006
3Messenger RNA (mRNA)IBA
06/2012 - 10/2006
2Biomarkers (Surrogate Marker)IBA
02/2019 - 11/2010
2CalciumIBA
01/2017 - 01/2017
2Bentonite (Montmorillonite)IBA
01/2017 - 01/2017
2AlbuminsIBA
01/2011 - 12/2010
2Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
11/2010 - 03/2009
1VitaminsIBA
02/2019
1IronIBA
02/2019
1ZincIBA
02/2019
1calcium silicate (Wollastonite)IBA
01/2017
1ACCS100IBA
01/2017
1fumonisin B1IBA
09/2016
1Proteins (Proteins, Gene)FDA Link
02/2015
1CytokinesIBA
02/2015
1SmectiteIBA
02/2015
1Interleukin-12 (IL 12)IBA
02/2015
1SolutionsIBA
07/2014
1CarcinogensIBA
09/2013
1LipidsIBA
09/2013
1Muramidase (Lysozyme)IBA
09/2013
1TrypsinIBA
09/2013
1CatalaseIBA
06/2012
1MycotoxinsIBA
07/2010

Therapy/Procedure

2Therapeutics
01/2017 - 02/2015
1Physical Therapy Modalities (Physical Therapy Technique)
01/2017